Palbocicilib

DRUG2 trials

Sponsors

National Cancer Institute (NCI), Beni-Suef University

Conditions

Advanced Clear Cell Renal Carcinoma (Ccrcc)Breast CancerPapillary Renal Cell Carcinoma (Prcc)

Phase 1

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

RecruitingNCT05665361

National Cancer Institute (NCI)Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc)

Start: 2024-04-24End: 2027-06-01Target: 100Updated: 2026-03-09

Phase 4

Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt

CompletedNCT07487129

Beni-Suef UniversityBreast Cancer

Start: 2024-08-25End: 2025-12-20Updated: 2026-03-23